94 Le théier
Dénominations Camellia sinensis (L.) Kuntze botaniques = Thea sinensis L. = C. thea Link
Autres Arbre à thé, camélia de Chine,
dénominations thé, thé noir, thé vert, thé de Chine (ou de Russie), thé vierge
Noms anglais Tea plant, tea bush, tea, common tea, black tea, green tea, Chinese (or japanese) tea, tea Camellia
Noms allemands Teestrauch,Tee, Schwarztee, Grüntee, Grüner Tee, Tee- Kamelie
Famille botanique Théacées ou Caméliacées ( Theaceae ou Camelliaceae)
Partie utilisée en Feuilles médecine

Description botanique du théier Théier théier pekoë Camellia sinensis (L.) Kuntze C. sinensis sinensis C. sinensis assamica Melaleuca alternifolia Leptospermum scoparium tea tree Camellia sinensis

Composition chimique des feuilles de théier 1, 2 Pharmacopée française e C. sinensis de novo80.
119 88 130
THÉ VERT 110
● Alcaloïdes
– 3
–
● Polyphénols
– Catéchines, O 180
– Proanthocyanidols
– Autres flavonoïdes ▪ 172 Flavonols ▪ Flavan-3-ols et des flavan-3,4-diols ▪ Dérivés de flavan-3-ols, 186 ▪ 186 Flavonoïdes glycosylés et méthylés ▪ Flavo-alcaloïdes C N 186
– Acides-phénols :
p
– Diterpènes :
– Esters galliques de glucoses :
78
● Saponines triterpéniques
● Acides organiques 79
● Huile essentielle trans cis
● Protéines et acides aminés (aa) L γ 170
– Glucides
–
– 170
● 170 Vitamines
–
–
● Minéraux 6 170
● Autres composants :
THÉ NOIR
●
● Saponosides triterpéniques et composés volatils
● Polyphénols oxydés :
.
– Théaflavine
– Théarubigènes
– Flavanol-gallates
● Acides organiques :
79
● 172 Autres polyphénols :
● Autres constituants :
L
● Minéraux :
170
● Vitamines :
170

Propriétés pharmacologiques des feuilles de théier Pharmacopée française

Usages reconnus 68 o 2
● par voie orale
–
–
–
–
● en usage local
–
– 88 170 L 88 130 83 73
183 L 162 75 75 80 C. sinensis 157 105, 168, 169 136 138 66, 71 139, 141 170 160 C. sinensis 176
Propriétés antioxydante, anti-inflammatoire et immunitaire
● In silico β O 168
● In vitro
– 110
– 34
● In vivo (rat)
– 2 2 123
– 109
● In vivo (souris)
– 80
– 82
– 110
● Chez l’Homme
– 79
– 174 Prevotella 175
– 129
Propriétés neuropsychique, cognitive et neuroprotectrice
● Activités psychostimulante et cognitive
– Mécanismes d’action ▪ 7, 8 12, 13 9, 10, 11 ▪ 170 110 in vitro C. sinensis 14 ▪ via 110 ▪ 112 ▪ 69 16
– Chez l’Homme ▪ 170 ▪ 23 ▪ La L-théanine • , via 15 • 17 18 187 • 20 • 76 • 188 ▪ 19 ▪ 22 ▪ 164
● Activités neuroprotectrice et antineurodégénérative
– Action dans la dépression et les troubles anxieux ▪ L 163 ▪ L 162 ▪ In vivo C. sinensis 161 ▪ 178
– Action dans les maladies neurodégénératives ▪ 181 ▪ 42 ▪ β α 101 ▪ 42 ▪ β β α in vitro in vivo Caenorhabditis elegans 150 ▪ L N 81 ▪ L 106 ▪ via β 173 ▪ In vivo 121
– Action dans l’ischémie cérébrale ▪ ▪ in vivo 41 110 135 ▪ 110
– Action lors de l’exposition à des substances neurotoxiques ▪ In vitro 113 ▪ In vivo (rat) • 114 • C. sinensis 171 ▪ 115
● Activité antalgique :
145
Propriétés hypolipémiante et cardiovasculaire
● Données épidémiologiques
– 88 94
– 92
– 93
– 91 95
– 170
● Mécanismes d’action
– C. sinensis 26 27
– β139
– 25 64
– In vivo C. sinensis 156
– 80 81
– 179
● Données cliniques
– C. sinensis 28
– 24 29
– 148
– 86
Propriétés métaboliques et antidiabétiques
● 170
● 88
● β 80
● In vitro α α 88
● α 78 in vitro 88 85
● In vivo
– Chez la souris ▪ via 88 ▪ 154 ▪ C. sinensis 147 ▪ α α 149 ▪ 108 122
– Chez le rat, β 88
– Chez le rat lors d’un régime riche en graisses ▪ C. sinensis in vitro 100 ▪ via β 88 90 ▪ 36 ▪ 81
– Chez le rat lors d’un régime alimentaire riche en fructose ▪ 32 ▪ 35
– Chez le rat rendu diabétique par administration de streptozotocine ▪ 137 ▪ via 142
● 40
● Chez l’Homme
– 30 31
– 97 120
– Synthèse des études cliniques ▪ 70 21 88 ▪ C. sinensis via 177
Propriétés digestives
● α 79
● in vivo 80
● In vivo
– Chez les rats ▪ via Adlercreutzia 96 ▪ via via 124
– Chez la souris ▪ Escherichia coli E. coli 125 ▪ C. sinensis zonula occludens 99
Propriétés anticancéreuses
● C. sinensis 158
●
– In vitro
– via 83
– 83
● via in vitro in vivo 103
● 45, 46 47, 48 49, 50, 51 52, 53 in vitro in vivo 83 84
● 54, 55 56 57 41 98
● 159
● 143
Propriétés antimicrobiennes37
● Activité antivirale
– Études précliniques ▪ 110 ▪ 102 ▪ C. sinensis 107 ▪ 87 in silico C. sinensis 127 In vitro 128 132 152 in vitro 185
– Chez l’Homme ▪ 67 ▪ 42, 43, 44 ▪ 185
● Activité antibactérienne
– Bifidobacterium Lactobacillus Enterococcus Escherichia coli Staphylococcus aureus, Shigella flexneri Salmonella enterica79.
– S. aureus S. epidermidis Salmonella typhi Salmonella typhimurium Salmonella enteritidis Listeria monocytogenes Shigella dysenteriae S. flexneri Bordetella pertussis Pseudomonas Clostridium Vibrio 37 V. cholerae 170 S. aureus E. coli189
– Pseudomonas aeruginosa C. sinensis S. aureus 165 37 β 39
– Streptococcus mutans 37 Porphyromonas gingivalis 111
– S. epidermidis Micrococcus luteus Brevibacterium linens Pseudomonas fluorescens Bacillus subtilis 38
– Helicobacter pylori Mycobacterium tuberculosis 110
● Activité antifongique :
C. sinensis Trichophyton ● Activité en dentisterie :
mentagrophytes T. rubrum Candida albicans 37 Cryptococcus neoformans in vitro C. albicans165 Aspergillus niger189
Propriétés protectrices au niveau buccal
● Activité dans la mucite buccale :
C. sinensis 118
● Activité au niveau gingival :
α 74
● Activité dans l’halitose
– 77
– 140
● Activité dans la gingivite, la parodontite et pour faciliter la préservation de l’état de santé bucco- dentaire
– C. sinensis 146
– C. sinensis 133
– 141 C. sinensis 131
Propriétés ostéoarticulaires
● Activité ostéoprotectrice
– In vivo via 105
– 168 via 169
● Activité antiarthrosique :
α 168
● Activité antiarthritique :
168
Autres propriétés
● Activité dermatologique
– Action dermoprotectrice ▪ D 180 ▪ 66 71
– Action protectrice capillaire :
C. sinensis 134
– Action antiacnéique :
151
● Activité pneumoprotectrice : in vivo
– 72 126
– C. sinensis 104
● Activité gynécologique
– 116
– 144
– 138
– 117
– 184
● Activité antisarcopénique :
136
● Activités hémolytique et thrombolytique :
189
–
– Principales indications thérapeutiques des feuilles de théier
● En rapport avec ses propriétés stimulantes sur la performance physique :
–
–
● En rapport avec ses propriétés psychostimulantes :
–
–
–
–
–
● En rapport avec ses propriétés cardiométaboliques et sur l’obésité :
–
–
–
–
–
–
–
–
–
● En rapport avec ses propriétés anti- infectieuses :
–
–
–
– Helicobacter pylori
–
–
● En rapport avec ses autres propriétés, notamment antioxydantes et anti- inflammatoires :
–
–
–
–
–
–
–
–
–
–
–
MODALITÉS D’UTILISATION DU
THÉIER
● 59 Toxicité
– 93
– 63 ▪ ▪ 58 61 ▪ 60 33 62 33 ▪ via 65 ▪ 68
● Contre-indications
–
–
– 68
– 167
– 144
–
● Effets secondaires
–
–
– 93
– In vivo 153
– LactMed 144
– C. sinensis C. sinensis
– C. sinensis C. sinensis167
● Précautions d’emploi
–
–
– 28
–
– ▪ ▪ ▪ ▪
– C. sinensis 167
–
–
– 33
–
EFSA
EFSA Panel 2018 167
● Interactions médicamenteuses
–
– ▪ ▪
– 170
–
– In vivo 155
–
FORMES ET PRÉPARATIONS Forme sèche :
182 Forme liquide
●
●
● Usage local :
PRINCIPALES FORMULES
UTILISANT LE THÉIER
AVEC D’AUTRES PLANTES ±
NUTRIMENTS OU SUBSTANCES
● Sous forme de complément alimentaire
– Avec le guarana + fucus ou maté ou nopal ou curcuma, ou bien son d’avoine et papaye, ou bien kola, papaye, citron, curcumine et zinc, ou bien vitamines/minéraux :
– Avec le guarana, l’artichaut, l’ascophyllum, la caroube, le kola, le curcuma, la chicorée + minéraux :
– Avec le guarana et le café vert ± reine des prés, ou bien papaye et ananas :
– Avec le guarana et le maté ± açaï (= palmier pinot) ou queue de cerise :
– Avec le kola, le carvi, l’ascophyllum et l’anis étoilé + bourgeons de bouleau, frêne et cassis
– Avec le café vert et le maté + hibiscus et framboise, ou bien le mélange romarin, tilleul, ascophyllum et reine des prés :
– Avec l’ananas :
– Avec l’aubier de tilleul, le fenouil et le frêne :
– Avec la reine des prés :
– Avec la reine des prés et le bouleau + frêne ou fenouil :
– Avec le bouleau et le fenouil + marc de raisin :
– Avec le konjac :
– Avec l’orthosiphon et le vinaigre de cidre :
– Avec le fenouil :
– Avec le pissenlit :
– Avec des algues laminaires :
– Avec le fenouil, l’eschscholtzia, la sauge, la maca et le soja + minéraux :
– Avec le romarin :
– Avec le gattilier, l’achillée millefeuille, la réglisse et le myrobolan chébule + Pycnogenol®, vitamine E et minéraux :
– Avec la myrtille + cassis, ou bien vitamine B6, minéraux et hyaluronate de sodium :
– Avec le curcuma et le pépin de raisin :
Fiche En savoir plus alias Gong Fu Cha chá tcha tea ti thé herbal tea a cup of tea Earl Grey1 Flowery Orange Pekoe Special Finest Tippy Golden Flowery Orange Pekoe One via
XVIIe Cha No Yu Gyokuro 130 166 Camellia sinensis 64 2 Tea for two 182 88 78 85 tea party

Bibliographie
1. WICHTL M., ANTON R., Plantes thérapeutiques. Tradition, pratique officinale, science et thérapeutique. Lavoisier « Tec & Doc », 1999, 550-3.
2. BRUNETON J., Pharmacognosie. Phytochimie et plantes médicinales. Lavoisier « Tec & Doc », 1999 (3e éd.), 1076.
3. FUJIMORI N. et al., Biosynthesis of Caffeine in Flower Buds of Camellia sinensis. Ann Bot, 1993 Mar; 71(3): 279-84.
4. KIMURA K. et al., L-Theanine reduces psychological and physiological stress responses. Biol Psychol, 2007 Jan; 74(1): 39-45.
5. LU K. et al., The acute effects of L-theanine in comparison with alprazolam on anticipatory anxiety in humans. Hum Psychopharmacol, 2004 Oct; 19(7): 457-65. 6. ANSES, Avis de l’Agence nationale de sécurité sanitaire de l’alimentation, de l’environnement et du travail relatif à la sécurité d'emploi des préparations de thé vert. [En ligne] https://www.anses.fr/fr/system/files/NUT2011sa0139.pdf. Consulté le 06 mars 2023. 7. FISONE G. et al., Caffeine as a psychomotor stimulant: mechanism of action. Cell Mol Life Sci, 2004 Apr; 61(7-8): 857-72.
8. CAULI O. et al., Caffeine and the dopaminergic system. Behav Pharmacol, 2005 Mar; 16(2): 63-77.
9. HECKMAN M.A. et al., Caffeine (1, 3, 7-trimethylxanthine) in foods: a comprehensive review on consumption, functionality, safety, and regulatory matters. J Food Sci, 2010 Apr; 75(3): R77-87.
10. HUANG Z.L. et al., The role of adenosine in the regulation of sleep. Curr Top Med Chem, 2011; 11(8): 1047-57.
11. PORKKA-HEISKANEN T., Methylxanthines and sleep. Handb Exp Pharmacol, 2011; (200): 331-48.
12. GLADE M.J., Caffeine-Not just a stimulant. Nutrition, 2010 Oct; 26(10): 932-8. 13. NEHLIG A., Is caffeine a cognitive enhancer? J Alzheimers Dis, 2010; 20 Suppl 1: S85-94.
14. JAZAYERI S.B. et al., A preliminary investigation of anticholinesterase activity of some Iranian medicinal plants commonly used in traditional medicine. Daru, 2014 Jan 8; 22(1): 17.
15. KIMURA K. et al., L-Theanine reduces psychological and physiological stress responses. Biol Psychol, 2007 Jan; 74(1): 39-45.
16. NATHAN P. et al., The neuropharmacology of L-theanine (N-ethyl-L-glutamine): a possible neuroprotective and cognitive enhancing agent. J Herb Pharmacother, 2006; 6(2): 21-30. 17. LU K. et al., The acute effects of L-theanine in comparison with alprazolam on anticipatory anxiety in humans. Hum Psychopharmacol, 2004 Oct; 19(7): 457-65. 18. RITSNER M.S. et al., L-theanine Relieves Positive, Activation, and Anxiety Symptoms in Patients with Schizophrenia and Schizoaffective Disorder : an 8-week, randomized, double-blind, placebo-controlled, 2-center study. J Clin Psychiatry, 2011 Jan; 72(1): 34-42.
19. HINDMARCH I. et al., The effects of black tea and other beverages on aspects of cognition and psychomotor performance. Psychopharmacol (Berl), 1998 Oct; 139(3): 230-8. 20. PARK S.K. et al., A combination of green tea extract and L-theanine improves memory and attention in subjects with mild cognitive impairment: a double-blind placebo-controlled study. J Med Food, 2011 Apr; 14(4): 334-43. 21. YANG W.S. et al., Tea consumption and risk of type 2 diabetes: a dose-response meta-analysis of cohort studies. Br J Nutr, 2014 Apr 28; 111(8): 1329-39.
22. SCHMIDT A. et al., Green tea extract enhances parieto-frontal connectivity during working memory processing. Psychopharmacology (Berl), 2014 Oct; 231(19): 3879-88. 23. KURIYAMA S. et al., Green tea consumption and cognitive function: a cross-sectional study from the Tsurugaya Project. Am J Clin Nutr, 2006 Feb; 83(2): 355-61. 24. KIM A. et al., Green tea catechins decrease total and low-density lipoprotein cholesterol: a systematic review and meta-analysis. J Am Diet Assoc, 2011 Nov; 111(11): 1720-9.
25. HOOPER L. et al., Flavonoids, flavonoid-rich foods, and cardiovascular risk: a meta-analysis of randomized controlled trials. Am J Clin Nutr, 2008 Jul; 88(1): 38-50.
26. NAGAO T. et al., A green tea extract high in catechins reduces body fat and cardiovascular risks in humans. Obesity (Silver Spring), 2007 Jun; 15(6): 1473-83. 27. MATSUYAMA T. et al., Catechin safely improved higher levels of fatness, blood pressure, and cholesterol in children. Obesity (Silver Spring), 2008 Jun; 16(6): 1338-48. 28. NANTZ M.P. et al., Standardized capsule of Camellia sinensis lowers cardiovascular risk factors in a randomized, double-blind, placebo-controlled study. Nutrition, 2009 Feb; 25(2): 147-54.
29. ZHENG X. et al., Green tea intake lowers fasting serum total and LDL cholesterol in adults: a meta-analysis of 14 randomized controlled trials. Am J Clin Nutr, 2011 Aug; 94(2): 601-10. 30. FUKINO Y. et al., Randomized controlled trial for an effect of green tea consumption on insulin resistance and inflammation markers. J Nutr Sci Vitaminol (Tokyo), 2005 Oct; 51(5): 335-42.
31. FUKINO Y. et al., Randomized controlled trial for an effect of green tea-extract powder supplementation on glucose abnormalities. Eur J Clin Nutr, 2008 Aug; 62(8): 953-60.
32. WU L.Y. et al., Green tea supplementation ameliorates insulin resistance and increases glucose transporter IV content in a fructose-fed rat model. Eur J Nutr, 2004 Apr; 43(2): 116-24.
33. OKETCH-RABAH H.A. et al., United States Pharmacopeia (USP) comprehensive review of the hepatotoxicity of green tea extracts. Toxicol Rep, 2020 Feb 15; 7: 386-402.
34. WANG Y.F. et al., Characterization and antioxidant activities of polysaccharides from leaves, flowers and seeds of green tea. Carbohyd Polym, 2012 Mar; 88(1): 146-53.
35. CAO H. et al., Green tea polyphenol extract regulates the expression of genes involved in glucose uptake and insulin signaling in rats fed a high fructose diet. J Agric Food Chem, 2007 Jul 25; 55(15): 6372-8.
36. ZHOU J. et al., Aqueous extract of post-fermented tea reverts the hepatic steatosis of hyperlipidemia rat by regulating the lipogenic genes expression and hepatic fatty acid composition. BMC Complement Altern Med, 2014 Jul 23; 14: 263. 37. HAMILTON-MILLER J.M., Antimicrobial properties of tea (Camellia sinensis L.). Antimicrob Agents Chemother, 1995 Nov; 39(11): 2375-7.
38. SHARMA A. et al., Green tea extract: possible mechanism and antibacterial activity on skin pathogens. Food Chem, 2012 Nov 15; 135(2): 672-5. 39. AQIL F. et al., Effect of certain bioactive plant extracts on clinical isolates of beta-lactamase producing methicillin resistant Staphylococcus aureus. J Basic Microbiol, 2005; 45(2): 106-14.
40. DULLOO A.G. et al., Green tea and thermogenesis: interactions between catechin-polyphenols, caffeine and sympathetic activity. Int J Obes Relat Metab Disord, 2000 Feb; 24(2): 252-8.
41. NAMITA P. et al., Camellia Sinensis (Green Tea): A Review. Glob J Pharmacol, 2012 Jan; 6(2): 52-9.
42. GROSS G. et al., A randomized, double-blind, four-arm parallel-group, placebo-controlled Phase II/III study to investigate the clinical efficacy of two galenic formulations of Polyphenon E in the treatment of external genital warts. J Eur Acad Dermatol Venereol, 2007 Nov; 21(10): 1404-12.
43. STOCKFLETH E. et al., Topical Polyphenon E in the treatment of external genital and perianal warts: a randomized controlled trial. Br J Dermatol, 2008 Jun; 158(6): 1329-38.
44. TATTI S. et al., Sinecatechins, a defined green tea extract, in the treatment of external anogenital warts: a randomized controlled trial. Obstet Gynecol, 2008 Jun; 111(6): 1371-9. 45. TANG N.P. et al., Tea consumption and risk of endometrial cancer: a metaanalysis. Am J Obstet Gynecol, 2009 Dec; 201(6): 605.e1-8.
46. KAKUTA Y. et al., Case-control study of green tea consumption and the risk of endometrial endometrioid adenocarcinoma. Cancer Causes Control, 2009; 20(5): 617-24.
47. LARSSON S.C. et al., Tea consumption and ovarian cancer risk in a population-based cohort. Arch Intern Med, 2005 Dec 12-26; 165(22): 2683-6. 48. ZHANG M. et al., Tea consumption and ovarian cancer risk: a case-control study in China. Cancer Epidemiol Biomarkers Prev, 2002 Aug; 11(8): 713-8.
49. SEELY D. et al., The effects of green tea consumption on incidence of breast cancer and recurrence of breast cancer: a systematic review and meta-analysis. Integr Cancer Ther, 2005 Jun; 4(2): 144-55.
50. SUN C.L. et al., Green tea, black tea and breast cancer risk: a meta-analysis of epidemiological studies. Carcinogenesis, 2006 Jul; 27(7): 1310-5. 51. OGUNLEYE A.A. et al., Green tea consumption and breast cancer risk or recurrence: a meta-analysis. Breast Cancer Res Treat, 2010 Jan; 119(2): 477-84. 52. SEELY D. et al., The effects of green tea consumption on incidence of breast cancer and recurrence of breast cancer: a systematic review and meta-analysis. Integr Cancer Ther, 2005 Jun; 4(2): 144-55.
53. SUZUKI Y. et al., Green tea and the risk of breast cancer: pooled analysis of two prospective studies in Japan. Br J Cancer, 2004 Apr 5; 90(7): 1361-3.
54. GAO Y.T. et al., Reduced risk of esophageal cancer associated with green tea consumption. J Natl Cancer Inst, 1994 Jun 1; 86(11): 855-8. 55. SUN C.L. et al., Urinary tea polyphenols in relation to gastric and esophageal cancers: a prospective study of men in Shanghai, China. Carcinogenesis, 2002 Sep; 23(9): 1497-503.
56. WANG L.D. et al., Intervention and follow-up on human esophageal precancerous lesions in Henan, northern China, a high-incidence area for esophageal cancer. Gan To Kagaku Ryoho, 2002 Feb; 29 Suppl 1: 159-72.
57. TSAO A.S. et al., Phase II randomized, placebo-controlled trial of green tea extract in patients with high-risk oral premalignant lesions. Cancer Prev Res (Phila), 2009 Nov; 2(11): 931-41.
58. DOSTAL A.M. et al., The safety of green tea extract supplementation in postmenopausal women at risk for breast cancer: results of the Minnesota Green Tea Trial. Food Chem Toxicol, 2015 Sep; 83: 26-35.
59. SARMA D.N. et al., Safety of green tea extracts: a systematic review by the US Pharmacopeia. Drug Saf, 2008; 31(6): 469-84.
60. ISOMURA T. et al., Liver-related safety assessment of green tea extracts in humans: a systematic review of randomized controlled trials. Eur J Clin Nutr, 2016; 70(11): 1340.
61. MAZZANTI G. et al., Hepatotoxicity from green tea: a review of the literature and two unpublished cases. Eur J Clin Pharmacol, 2009; 65(4): 331-41.
62. CHURCH R.J. et al., Sensitivity to hepatotoxicity due to epigallocatechin gallate is affected by genetic background in diversity outbred mice. Food Chem Toxicol, 2015 Feb; 76: 19-26. 63. GARCÍA-CORTÉS M. et al., Hepatotoxicity by dietary supplements: a tabular listing and clinical characteristics. Int J Mol Sci, 2016; 17(4): 537.
64. LORENZ M. et al., Green and black tea are equally potent stimuli of NO production and vasodilation: new insights into tea ingredients involved. Basic Res Cardiol, 2009 Jan; 104(1): 100-10.
65. CANNEVA A. et al., Extraits de thé vert et hépatotoxicité : un réel danger ? Institut national de santé publique du Québec (INSPQ). Bulletin d’information toxicologique, Juin 2017 ; 33(2) : 13-8.
66. JANJUA R. et al., A two-year, double-blind, randomized placebo-controlled trial of oral green tea polyphenols on the long-term clinical and histologic appearance of photoaging skin. Dermatol surg, 2009 Jul; 35(7): 1057-65.
67. MATSUMOTO K. et al., Effects of Green Tea Catechins and Theanine on Preventing Influenza Infection among Healthcare Workers: A Randomized Controlled Trial. BMC Complement Altern Med, 2011 Feb 21; 11: 15.
68. EUROPEAN MEDICINES AGENCY, Assessment report on Camellia sinensis (L.) Kuntze, non fermentatum folium. Final. 12 November 2013. EMA/HMPC/283629/2012. Et: Addendum to Assessment report on Camellia sinensis (L.) Kuntze, non fermentatum folium. 20 July 2022. EMA/HMPC/30571/2022. Et: Community herbal monograph on Camellia sinensis (L.) Kuntze, non fermentatum folium. Final. 12 November 2013. EMA/HMPC/283630/2012.
69. SAEED M. et al., Green tea (Camellia sinensis) and l-theanine: Medicinal values and beneficial applications in humans-A comprehensive review. Biomed Pharmacother, 2017 Nov; 95: 1260-75.
70. ASBAGHI O. et al., Effect of green tea on glycemic control in patients with type 2 diabetes mellitus: A systematic review and meta-analysis. Diabetes Metab Syndr, 2021 Jan-Feb; 15(1): 23-31.
71. PRASANTH M.I. et al., A Review of the Role of Green Tea (Camellia sinensis) in Antiphotoaging, Stress Resistance, Neuroprotection, and Autophagy. Nutrients, 2019 Feb 23; 11(2): 474.
72. CHAKRABORTY K. et al., Anti-fibrotic effect of black tea (Camellia sinensis) extract in experimental pulmonary fibrosis. Tissue Cell, 2019 Feb; 56: 14-22.
73. XING L. et al., Recent Advances in the Understanding of the Health Benefits and Molecular Mechanisms Associated with Green Tea Polyphenols. J Agric Food Chem, 2019 Jan 30; 67(4): 1029-43.
74. LAGHA A.B. et al., Tea polyphenols protect gingival keratinocytes against TNF-α-induced tight junction barrier dysfunction and attenuate the inflammatory response of monocytes/macrophages. Cytokine, 2019 Mar; 115: 64-75.
75. WILLIAMS J. et al., The beneficial health effects of green tea amino acid L-theanine in animal models: Promises and prospects for human trials. Phytother Res, 2019 Mar; 33(3): 571-83.
76. SARRIS J. et al., L-theanine in the adjunctive treatment of generalized anxiety disorder: A double-blind, randomised, placebo-controlled trial. J Psychiatr Res, 2019 Mar; 110: 31-7. 77. TAHANI B. et al., Effect of Camellia sinensis plant on decreasing the level of halitosis: A systematic review. Dent Res J (Isfahan), 2018 Nov-Dec; 15(6): 379-84.
78. TOLMIE M. et al., The potential antidiabetic properties of green and purple tea [Camellia sinensis (L.) O Kuntze], purple tea ellagitannins, and urolithins. J Ethnopharmacol, 2023 Mar 10: 116377.
79. CHEN H. et al., Quality Chemistry, Physiological Functions, and Health Benefits of Organic Acids from Tea (Camellia sinensis). Molecules, 2023 Mar 3; 28(5): 2339. 80. PAN H. et al., Dark tea: A popular beverage with possible medicinal application. Chin Herb Med, 2022 Nov 24; 15(1): 33-6.
81. LIN F.J. et al., State-of-the-art review of dark tea: From chemistry to health benefits. Trends Food Sci, 2021 Mar; 109: 126-38.
82. NINSIIMA H.I. et al., Green tea silver nanoparticles improve physiological motor and cognitive function in BALB/c mice during inflammation. Heliyon, 2023 Feb 21; 9(3): e13922.
83. PARISH M. et al., Green Tea in Reproductive Cancers: Could Treatment Be as Simple? Cancers (Basel), 2023 Jan 30; 15(3): 862.
84. YAP J. et al., Sinecatechins ointment as a potential novel treatment for usual type vulval intraepithelial neoplasia: a single-centre double-blind randomised control study. BJOG, 2021 May; 128(6): 1047-55.
85. DA SILVA T.B.V. et al., Purple tea: chemical characterization and evaluation as inhibitor of pancreatic lipase and fat digestion in mice. Food Funct, 2023 Feb 6; 14(3): 1761-72.
86. YILDIRIM AYAZ E. et al., Effect of Green Tea on Blood Pressure in Healthy Individuals: A Meta-Analysis. Altern Ther Health Med, 2023 Jul; 29(5): 66-73. 87. BARANOVA A. et al., Causal associations of tea intake with COVID-19 infection and severity. Front Nutr, 2023 Jan 4; 9: 1005466.
88. BRIMSON J.M. et al., Tea Plant (Camellia sinensis): A Current Update on Use in Diabetes, Obesity, and Cardiovascular Disease. Nutrients, 2022 Dec 21; 15(1): 37.
89. YUAN E. et al., Aged Oolong Tea Reduces High-Fat Diet-Induced Fat Accumulation and Dyslipidemia by Regulating the AMPK/ACC Signaling Pathway. Nutrients, 2018 Feb 8; 10(2): 187.
90. TIAN C. et al., Green tea polyphenols reduced fat deposits in high fat-fed rats via erk1/2-PPARγ-adiponectin pathway. PLoS One, 2013; 8(1): e53796. 91. BAG S. et al., Tea and its phytochemicals: Hidden health benefits & modulation of signaling cascade by phytochemicals. Food Chem, 2022 Mar 1; 371: 131098.
92. CHUNG M. et al., Dose-Response Relation between Tea Consumption and Risk of Cardiovascular Disease and All-Cause Mortality: A Systematic Review and Meta-Analysis of Population-Based Studies. Adv Nutr, 2020 Jul 1; 11(4): 790-814. 93. KELLER A. et al., Tea intake and cardiovascular disease: an umbrella review. Ann Med, 2021 Dec; 53(1): 929-44.
94. GAEINI Z. et al., Tea, coffee, caffeine intake and the risk of cardio-metabolic outcomes: findings from a population with low coffee and high tea consumption. Nutr Metab (Lond), 2019 May 3; 16: 28.
95. SAMANTA S. Potential Bioactive Components and Health Promotional Benefits of Tea (Camellia sinensis). J Am Nutr Assoc, 2022 Jan; 41(1): 65-93.
96. COSTA M.A.C. et al., Kombuchas from Green and Black Tea Modulate the Gut Microbiota and Improve the Intestinal Health of Wistar Rats Fed a High-Fat High-Fructose Diet. Nutrients, 2022 Dec 8; 14(24): 5234.
97. RONDANELLI M. et al., A 60-Day Green Tea Extract Supplementation Counteracts the Dysfunction of Adipose Tissue in Overweight Post-Menopausal and Class I Obese Women. Nutrients, 2022 Dec 7; 14(24): 5209.
98. LI X.X. et al., Anticarcinogenic potentials of tea catechins. Front Nutr, 2022 Dec 5; 9: 1060783.
99. LIU H. et al., Tea (Camellia sinensis) ameliorates DSS-induced colitis and liver injury by inhibiting TLR4/NF-κB/NLRP3 inflammasome in mice. Biomed Pharmacother, 2023 Feb; 158: 114136.
100. ANSARI P. et al., Antidiabetic Actions of Ethanol Extract of Camellia sinensis Leaf Ameliorates Insulin Secretion, Inhibits the DPP-IV Enzyme, Improves Glucose Tolerance, and Increases Active GLP-1 (7-36) Levels in High-Fat-Diet-Fed Rats. Medicines (Basel), 2022 Nov 11; 9(11): 56.
101. AFZAL O. et al., Green Tea Catechins Attenuate Neurodegenerative Diseases and Cognitive Deficits. Molecules, 2022 Nov 6; 27(21): 7604. 102. IIJIMA M. et al., Nano-visualization of the in vitro antiviral activity of black tea based on production area using a liposome-based virus membrane model. Biosci Biotechnol Biochem, 2022 Nov 23; 86(12): 1658-69.
103. FARHAN M. Green Tea Catechins: Nature's Way of Preventing and Treating Cancer. Int J Mol Sci, 2022 Sep 14; 23(18): 10713.
104. SHIN D.U. et al., Camellia sinensis L. Alleviates Pulmonary Inflammation Induced by Porcine Pancreas Elastase and Cigarette Smoke Extract. Antioxidants (Basel), 2022 Aug 28; 11(9): 1683.
105. KULKARNI C. et al., A novel extraction method enhanced the osteogenic and anti-osteoporosis effect of tea extract without any hepatotoxicity in ovariectomized rats. Front Endocrinol (Lausanne), 2022 Aug 8; 13: 951800.
106. XIE X. et al., Synergistic effects of epigallocatechin gallate and L-theanine in nerve repair and regeneration by anti-amyloid damage, promoting metabolism, and nourishing nerve cells. Front Nutr, 2022 Aug 10; 9: 951415.
107. ABD-ELSHAFY D.N. et al., Addition of Camellia sinensis extract to water to disinfect respiratory viruses accumulated over different surfaces. J Water Health, 2022 Jul; 20(7): 1102-11.
108. WU D. et al., Tea (Camellia sinensis) Ameliorates Hyperuricemia via Uric Acid Metabolic Pathways and Gut Microbiota. Nutrients, 2022 Jun 27; 14(13): 2666.
109. BERILLI P. et al., White tea modulates antioxidant defense of endurance-trained rats. Curr Res Physiol, 2022 Jun 18; 5: 256-64.
110. ZHAO T. et al., Green Tea (Camellia sinensis): A Review of Its Phytochemistry, Pharmacology, and Toxicology. Molecules, 2022 Jun 18; 27(12): 3909. 111. FOURNIER-LARENTE J. et al., Green tea catechins potentiate the effect of antibiotics and modulate adherence and gene expression in Porphyromonas gingivalis. Arch Oral Biol, 2016 May; 65: 35-43.
112. XU Y. et al., Green tea polyphenols inhibit cognitive impairment induced by chronic cerebral hypoperfusion via modulating oxidative stress. J Nutr Biochem, 2010 Aug; 21(8): 741-8.
113. TAI K.K. et al., (-)-Epigallocatechin-3-gallate (EGCG), a green tea polyphenol, reduces dichlorodiphenyl-trichloroethane (DDT)-induced cell death in dopaminergic SHSY-5Y cells. Neurosci Lett, 2010 Oct 4; 482(3): 183-7.
114. KHALAF A.A. et al., The protective effect of green tea extract on lead induced oxidative and DNA damage on rat brain. Neurotoxicology, 2012 Jun; 33(3): 280-9.
115. SONG Y. et al., Green tea polyphenols improve isoflurane-induced cognitive impairment via modulating oxidative stress. J Nutr Biochem, 2019 Nov; 73: 108213. 116. GU Q. et al., Green tea catechin EGCG could prevent obesity-related precocious puberty through NKB/NK3R signaling pathway. J Nutr Biochem, 2022 Oct; 108: 109085.
117. COLONETTI L. et al., Green tea promotes weight loss in women with polycystic ovary syndrome: Systematic review and meta-analysis. Nutr Res, 2022 Aug; 104: 1-9.
118. FERREIRA A.S. et al., Natural Products for the Prevention and Treatment of Oral Mucositis-A Review. Int J Mol Sci, 2022 Apr 15; 23(8): 4385. 119. WONG M. et al., Phytochemical profile of differently processed tea: A review. J Food Sci, 2022 May; 87(5): 1925-42.
120. FARIA N.C. et al., Acute green tea infusion ingestion effect on energy metabolism, satiety sensation and food intake: A randomized crossover trial. Clin Nutr ESPEN, 2022 Apr; 48: 63-7.
121. BAGCHI A. et al., Comparative assessment of organic and inorganic tea leaf extract feeding on anxiety behaviour status of colchicine-induced rat model of Alzheimer's disease. Inflammopharmacology, 2022 Apr; 30(2): 609-20.
122. CHEN Y. et al., The chemistry, processing, and preclinical anti-hyperuricemia potential of tea: a comprehensive review. Crit Rev Food Sci Nutr, 2023; 63(24): 7065-90.
123. ABDULAALI AZEEZ A. et al., Effect of Camellia sinensis on Fat Peroxidation and Ox-LDL in Rats. Arch Razi Inst, 2021 Oct 31; 76(4): 949-55.
124. HAMAD SHAREEF S. et al., Hepatoprotective effects of methanolic extract of green tea against Thioacetamide-Induced liver injury in Sprague Dawley rats. Saudi J Biol Sci, 2022 Jan; 29(1): 564-73.
125. KIM J.W. et al., Prophylactic Catechin-Rich Green Tea Extract Treatment Ameliorates Pathogenic Enterotoxic Escherichia coli-Induced Colitis. Pathogens, 2021 Dec 2; 10(12): 1573.
126. ZHAO Y. et al., Black Tea Alleviates Particulate Matter-Induced Lung Injury via the Gut-Lung Axis in Mice. J Agric Food Chem, 2021 Dec 22; 69(50): 15362-73. 127. LIU SY. et al., Discovery of Camellia sinensis catechins as SARS-CoV-2 3CL protease inhibitors through molecular docking, intra and extra cellular assays. Phytomedicine, 2022 Feb; 96: 153853.
128. ISHIMOTO K. et al., Tea crude extracts effectively inactivate severe acute respiratory syndrome coronavirus 2. Lett Appl Microbiol, 2022 Jan; 74(1): 2-7.
129. ROJANO-ORTEGA D. Regular, but not acute, green tea supplementation increases total antioxidant status and reduces exercise-induced oxidative stress: a systematic review. Nutr Res, 2021 Oct; 94: 34-43.
130. SAMYNATHAN R. et al., Recent insights on tea metabolites, their biosynthesis and chemo-preventing effects: A review. Crit Rev Food Sci Nutr, 2023; 63(18): 3130-49. 131. VALADAS L.A.R. et al., Camellia sinensis in Dentistry: Technological Prospection and Scientific Evidence. Evid Based Complement Alternat Med, 2021 Aug 30; 2021: 9966738. 132. TAKEDA Y. et al., Severe Acute Respiratory Syndrome Coronavirus-2 Inactivation Activity of the Polyphenol-Rich Tea Leaf Extract with Concentrated Theaflavins and Other Virucidal Catechins. Molecules, 2021 Aug 8; 26(16): 4803.
133. FURQUIM DOS SANTOS CARDOSO V. et al., Efficacy of medicinal plant extracts as dental and periodontal antibiofilm agents: A systematic review of randomized clinical trials. J Ethnopharmacol, 2021 Dec 5; 281: 114541.
134. DAVIS S.L. et al., Protection of hair from damage induced by ultraviolet irradiation using tea (Camellia sinensis) extracts. J Cosmet Dermatol, 2022 May; 21(5): 2246-54. 135. MACHIN A. et al., The effect of Camellia sinensis (green tea) with its active compound EGCG on neuronal cell necroptosis in Rattus norvegicus middle cerebral artery occlusion (MCAO) model. J Basic Clin Physiol Pharmacol, 2021 Jun 25; 32(4): 527-31.
136. SEO H. et al., (-)-Epicatechin-Enriched Extract from Camellia sinensis Improves Regulation of Muscle Mass and Function: Results from a Randomized Controlled Trial. Antioxidants (Basel), 2021 Jun 25; 10(7): 1026.
137. GUIMARÃES-ERVILHA L.O. et al., Green Tea Infusion Ameliorates Histological Damages in Testis and Epididymis of Diabetic Rats. Microsc Microanal, 2021 Jun 29: 1-13. 138. KAMAL D.A.M. et al., Beneficial Effects of Green Tea Catechins on Female Reproductive Disorders: A Review. Molecules, 2021 May 3; 26(9): 2675.
139. MODESTO P.N. et al., Green Tea (Camellia sinensis) Extract Increased Topoisomerase IIβ, Improved Antioxidant Defense, and Attenuated Cardiac Remodeling in an Acute Doxorubicin Toxicity Model. Oxid Med Cell Longev, 2021 May 5; 2021: 8898919.
140. ALZOMAN H. et al., Efficacy of Arabic Coffee and Black Tea in Reducing Halitosis: A Randomized, Double-Blind, Controlled, Crossover Clinical Trial. Healthcare (Basel), 2021 Mar 1; 9(3): 250.
141. MAZUR M. et al., Impact of Green Tea (Camellia Sinensis) on periodontitis and caries. Systematic review and meta-analysis. Jpn Dent Sci Rev, 2021 Nov; 57: 1-11.
142. LADEIRA L.C.M. et al., Green tea infusion prevents diabetic nephropathy aggravation in recent-onset type 1 diabetes regardless of glycemic control. J Ethnopharmacol, 2021 Jun 28; 274: 114032.
143. WIESE F. et al., Green tea and green tea extract in oncological treatment: A systematic review. Int J Vitam Nutr Res, 2023 Feb; 93(1): 72-84.
144. DRUGS AND LACTATION DATABASE (LACTMED®). [En ligne]. Green Tea. Bethesda (MD): National Institute of Child Health and Human Development;
https://www.ncbi.nlm.nih.gov/books/NBK501922/ 2006– 2021 Feb 15. 145. NEGAH S.S. et al., The Potential Role of Green Tea and its Main Constituent (Epigallocatechin -3-Gallate) in Pain Relief: A Mechanistic Review. Curr Drug Discov Technol, 2021; 18(6): e130921189586.
146. TAFAZOLI A. et al., Camellia Sinensis Mouthwashes in Oral Care: a Systematic Review. J Dent (Shiraz), 2020 Dec; 21(4): 249-62.
147. LIN Y.C. et al., Purple-leaf tea (Camellia sinensis L.) ameliorates high-fat diet induced obesity and metabolic disorder through the modulation of the gut microbiota in mice. BMC Complement Med Ther, 2020 Dec 10; 20(1): 376.
148. IGHO-OSAGIE E. et al., Short-Term Tea Consumption Is Not Associated with a Reduction in Blood Lipids or Pressure: A Systematic Review and Meta-Analysis of Randomized Controlled Trials. J Nutr, 2020 Dec 10; 150(12): 3269-79.
149. ZHAO G. et al., Tea Drinking Alleviates Diabetic Symptoms via Upregulating Renal Water Reabsorption Proteins and Downregulating Renal Gluconeogenic Enzymes in db/db Mice. Mol Nutr Food Res, 2020 Oct 13: e2000505.
150. ZHANG S. et al., Neuroprotective effects of Oolong tea extracts against glutamate-induced toxicity in cultured neuronal cells and β-amyloid-induced toxicity in Caenorhabditis elegans. Food Funct, 2020 Sep 23; 11(9): 8179-92.
151. KIM S. et al., The effects of green tea on acne vulgaris: A systematic review and meta-analysis of randomized clinical trials. Phytother Res, 2021 Jan; 35(1): 374-83. 152. MHATRE S. et al., Antiviral activity of green tea and black tea polyphenols in prophylaxis and treatment of COVID-19: A review. Phytomedicine, 2021 May; 85: 153286.
153. VIEIRA J.I.T. et al., Effect of green tea extract (Camellia sinensis) on the spermatic parameters of Wistar rats submitted or not to testicular heat shock. Anim Reprod, 2020 May 28; 17(2): e20190049.
154. BOLIN A.P. et al., Adipogenic commitment induced by green tea polyphenols remodel adipocytes to a thermogenic phenotype. J Nutr Biochem, 2020 Sep; 83: 108429. 155. HUANG S. et al., Effect of Green Tea and (-)-Epigallocatechin Gallate on the Pharmacokinetics of Rosuvastatin. Curr Drug Metab, 2020; 21(6): 471-8.
156. FERREIRA M.C.L. et al., Effect of Camellia sinensis teas on left ventricular hypertrophy and insulin resistance in dyslipidemic mice. Braz J Med Biol Res, 2020; 53(5): e9303.
157. ENGELHARDT U.H. Tea chemistry - What do and what don't we know? - A micro review. Food Res Int, 2020 Jun; 132: 109120.
158. MUSIAL C. et al., Beneficial Properties of Green Tea Catechins. Int J Mol Sci, 2020 Mar 4; 21(5): 1744.
159. FILIPPINI T. et al., Green tea (Camellia sinensis) for the prevention of cancer. Cochrane Database Syst Rev, 2020 Mar 2; 3(3): CD005004.
160. CHEN J. et al., Beneficial effects of green tea on age related diseases. Front Biosci (Schol Ed), 2020 Jan 1; 12(1): 70-91.
161. YE M. et al., Effects of Camellia Sinensis Extract on Repeated Restraint Stress-Induced Ovariectomized Female Rats. Biomed Res Int, 2019 Jul 24; 2019: 1926352.
162. LOPES SAKAMOTO F. et al., Psychotropic effects of L-theanine and its clinical properties: From the management of anxiety and stress to a potential use in schizophrenia. Pharmacol Res, 2019 Sep; 147: 104395.
163. ROTHENBERG D.O. et al., Mechanisms Underlying the Anti-Depressive Effects of Regular Tea Consumption. Nutrients, 2019 Jun 17; 11(6): 1361.
164. KAKUTANI S. et al., Green Tea Intake and Risks for Dementia, Alzheimer's Disease, Mild Cognitive Impairment, and Cognitive Impairment: A Systematic Review. Nutrients, 2019 May 24; 11(5): 1165.
165. KHAN I. et al., Antimicrobial potential of aqueous extract of Camellia sinensis against representative microbes. Pak J Pharm Sci, 2019 Mar; 32(2): 631-6. 166. DOU Q.P., Tea in Health and Disease. Nutrients, 2019 Apr 25; 11(4): 929.
167. ANSES, Avis de l’Agence nationale de sécurité sanitaire de l’alimentation, de l’environnement et du travail relatif à « l’évaluation de la pertinence de l’application des avertissements et recommandations exprimés dans les monographies de plantes médicinales de l’EMA aux compléments alimentaires contenant ces mêmes plantes ». 19 avril 2023. [En ligne] https://www.anses.fr/fr/system/files/NUT2019SA0155.pdf. Consulté le 22 août 2023. 168. XIE X. et al., Potential mechanism of tea for treating osteoporosis, osteoarthritis, and rheumatoid arthritis. Front Med (Lausanne), 2024 Feb 14; 11: 1289777. 169. KARIMI SM. et al., Plant-derived natural medicines for the management of osteoporosis: A comprehensive review of clinical trials. J Tradit Complement Med, 2023 Aug 5; 14(1): 1-18.
170. LUO Q. et al., Biological potential and mechanisms of Tea's bioactive compounds: An Updated review. J Adv Res, 2023 Dec 5: S2090-1232(23)00378-8.
https://doi.org/10.1016/j.jare.2023.12.004.
171. MAITI S. et al., Green tea (Camellia sinensis) protects against arsenic neurotoxicity via antioxidative mechanism and activation of superoxide dismutase activity. Cent Nerv Syst Agents Med Chem, 2017; 17(3): 187-95.
172. JEGANATHAN B. et al., Genetic Variation of Flavonols Quercetin, Myricetin, and Kaempferol in the Sri Lankan Tea ( Camellia sinensis L.) and Their Health-Promoting Aspects. Int J Food Sci, 2016; 2016: 6057434.
173. ALEXANDER C. et al., Polyherbal and Multimodal Treatments: Kaempferol- and Quercetin-Rich Herbs Alleviate Symptoms of Alzheimer's Disease. Biology (Basel), 2023 Nov 20; 12(11): 1453.
174. TANAKA Y. et al., Inhibitory effects on acute upper respiratory tract inflammation with black tea consumption. A randomized single-blind parallel-group, placebo-controlled study. Jpn Pharmacol Ther, 2021 ; 49 (2): 273-88.
175. TOMIOKA R. et al., The Effects of Black Tea Consumption on Intestinal Microflora-A Randomized Single-Blind Parallel-Group, Placebo-Controlled Study. J Nutr Sci Vitaminol (Tokyo), 2023; 69(5): 326-39.
176. LU Y. et al., Uptake and translocation of organic pollutants in Camellia sinensis (L.): a review. Environ Sci Pollut Res Int, 2023 Dec; 30(56): 118133-48. 177. PARK J. et al., Could Natural Products Help in the Control of Obesity? Current Insights and Future Perspectives. Molecules, 2023 Sep 13; 28(18): 6604.
178. MINNÉ D. et al., The effects of tea polyphenols on emotional homeostasis: Understanding dementia risk through stress, mood, attention & sleep. Clin Nutr ESPEN, 2023 Oct; 57: 77-88.
179. AZAMI S. et al., Therapeutic potentialities of green tea (Camellia sinensis) in ischemic stroke: biochemical and molecular evidence. Metab Brain Dis, 2024 Feb; 39(2): 347-57. 180. MESSIRE G. et al., Antioxidant Effects of Catechins (EGCG), Andrographolide, and Curcuminoids Compounds for Skin Protection, Cosmetics, and Dermatological Uses: An Update. Antioxidants (Basel), 2023 Jun 21; 12(7): 1317.
181. JIANG N. et al., Tea intake or consumption and the risk of dementia: a meta-analysis of prospective cohort studies. PeerJ, 2023 Jul 18; 11: e15688.
182. PHUAH Y.Q. et al., A review on matcha: Chemical composition, health benefits, with insights on its quality control by applying chemometrics and multi-omics. Food Res Int, 2023 Aug; 170: 113007.
183. SOUSA-FILHO C.P.B. et al., Green tea actions on miRNAs expression - An update. Chem Biol Interact, 2023 Jun 1; 378: 110465.
184. HAZIMEH D. et al., Green Tea and Benign Gynecologic Disorders: A New Trick for An Old Beverage? Nutrients, 2023 Mar 16; 15(6): 1439. 185. DINDA B. et al., Therapeutic potential of green tea catechin, (-)-epigallocatechin-3-O-gallate (EGCG) in SARS-CoV-2 infection: Major interactions with host/virus proteases. Phytomed Plus, 2023 Feb; 3(1): 100402.
186. SHI J. et al., Updates on the chemistry, processing characteristics, and utilization of tea flavonoids in last two decades (2001-2021). Crit Rev Food Sci Nutr, 2023; 63(20): 4757-84. 187. SHAMABADI A. et al., L-Theanine adjunct to risperidone in the treatment of chronic schizophrenia inpatients: a randomized, double-blind, placebo-controlled clinical trial. Psychopharmacology (Berl), 2023 Dec; 240(12): 2631-40.
188. SHAMABADI A. et al., l-theanine adjunct to sertraline for major depressive disorder: A randomized, double-blind, placebo-controlled clinical trial. J Affect Disord, 2023 Jul 15; 333: 38-43.
189. RAFIQUE S. et al., Investigation of the antimicrobial, antioxidant, hemolytic, and thrombolytic activities of Camellia sinensis, Thymus vulgaris, and Zanthoxylum armatum ethanolic and methanolic extracts. Food Sci Nutr, 2023 Jul 24; 11(10): 6303-11.
Notes
1. L'Earl Grey est un mélange de thé noir aromatisé à l'huile essentielle de bergamote.
Twinings commercialisa le premier Earl Grey's tea sur le marché britannique. Le mélange de Twinings © contient du thé de Chine, du Darjeeling, du thé de Ceylan ainsi qu'une petite quantité de Lapsang souchong, un thé noir fumé et corsé. Jacksons of Piccadilly© revendique également la paternité du Earl Grey et affirme avoir reçu la recette en 1830 de la part du comte Grey.
La rivalité entre les deux maisons se poursuit, bien qu'elles soient aujourd'hui liées à la même maison mère (source :
Wikipédia).
2. An apple a day keeps the doctor away !
dont la version francophone est « Une pomme le matin éloigne le médecin ! » . On n’ose d’ailleurs plus guère proclamer « mangez des pommes ! » pour promouvoir un mode de vie sain et une alimentation équilibrée, depuis que le slogan a été préempté par un ancien président de la République française…